A Natural History Study of Corneal Abrasions in Patients With Dystrophic Epidermolysis Bullosa (DEB)

ConditionsEpidermolysis Bullosa Dystrophica Epidermolysis Bullosa Dystrophica, Recessive Epidermolysis Bullosa Dystrophica Dominans

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age6+

SponsorKrystal Biotech, Inc.

About this trial

This study is a non-interventional, observational study that will evaluate the natural history of corneal abrasions in patients with Dystrophic Epidermolysis Bullosa (DEB).

Eligibility criteria

Qualifiers

The subject or their respective legal guardian must have read, understood, and signed an Institutional Review Board (IRB) approved Informed Consent/Assent Form and must be able to and willing to follow study procedures and instructions.

Age 6 months or older at time of Informed Consent/Assent.

Prior genetic diagnosis of DEB due to mutation(s) in the collagen type VII alpha 1 chain (COL7A1) gene.

Disqualifiers

None

Trial design

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Sponsors and collaborators

Krystal Biotech, Inc.

Lead sponsor

Source ClinicalTrials.gov